Zobrazeno 1 - 10
of 15
pro vyhledávání: '"63"'
Autor:
Julien Forestier, Jean-Yves Scoazec, Cécile Vercherat, Valérie Hervieu, Thomas Walter, Marie-Odile Joly, Catherine Lombard-Bohas, Anne-Sophie Dussol
Publikováno v:
Cancer. 121:3428-3434
BACKGROUND The alkylating agents (ALKYs) streptozotocin, dacarbazine, and temozolomide currently are the main drugs used in systemic chemotherapy for neuroendocrine tumors (NETs). The promising activity shown by gemcitabine and oxaliplatin (GEMOX) in
Autor:
Patrizio Rigatti, Massimo Freschi, Alberto Briganti, Nazareno Suardi, Andrea Salonia, Giovanni Lughezzani, Alexander Mottrie, Francesco Montorsi, Andrea Gallina, Umberto Capitanio
Publikováno v:
Cancer. 118:973-980
BACKGROUND: The authors tested the performance of the currently used clinical criteria reported in populations studied by van den Bergh et al and Carter et al for the selection of patients with prostate cancer (PCa) for active surveillance (AS) accor
Autor:
Hans C. Lee, Ashraf Badros, Attaya Suvannasankha, Peter M. Voorhees, Joanna Opalinska, Suzanne Trudel, Ajai Chari, Katja Weisel, Sagar Lonial, Al-Ola Abdallah, Lynsey Womersley, Trisha Piontek, Adam D. Cohen, Eric Lewis, Natalie S. Callander, January Baron, Ajay K. Nooka, Ira Gupta, Douglas W. Sborov
Publikováno v:
Cancer
Background On the basis of the DREAMM‐2 study (ClinicalTrials.gov identifier NCT03525678), single‐agent belantamab mafodotin (belamaf) was approved for patients with relapsed or refractory multiple myeloma (RRMM) who received ≥4 prior therapies
Publikováno v:
Cancer. 124:507-513
BACKGROUND Because of the recent grade C draft recommendation by the US Preventive Services Task Force (USPSTF) for prostate cancer screening between the ages of 55 and 69 years, there is a need to determine whether this could be cost-effective in a
Autor:
Andrea L. Cheville, Jean G. Haas, Karen M. Graszer, Pamela J. Netzel, Matthew M. Clark, Jean M. Hanson, Yolanda I. Garces, Teresa A. Rummans, Maria I. Lapid, Marlene H. Frost, Paul D. Brown, Jarrett W. Richardson, Katherine M. Piderman, Pamela J. Atherton, Mary E. Johnson, Jeff A. Sloan, Janis J. Miller
Publikováno v:
Cancer. 119:880-887
BACKGROUND: Psychosocial interventions often address only 1 domain of quality of life (QOL), are offered to patients with early-stage cancer, do not include the caregiver, and are delivered after cancer treatment has been completed. METHODS: In the c
Autor:
Eduard J. Gamito, Mark Dignan, Carol Thiel, Linda Burhansstipanov, Pamela Iron, Linda U. Krebs, Judith S. Kaur, Brenda F. Seals, Alice Bradley
Publikováno v:
Cancer. 116:1560-1571
Breast cancer associated morbidity issues for Native American patients have never been reported. To our knowledge, this paper is the first report of these experiences. Because this is the first of several papers on findings from the “Native America
Autor:
Manoj Pandey, Thara Somanathan, K. Najeeb, Elizabeth K. Abraham, Kunnambath Ramadas, Paola Pisani, Gigi Thomas, Binu Jose Jacob, Rengaswamy Sankaranarayanan, Babu Mathew
Publikováno v:
Cancer. 88:664-673
BACKGROUND Oral cancer satisfies the criteria for a suitable disease for screening, and oral visual inspection is a suitable test for oral cancer screening. The efficacy of screening in reducing mortality from oral cancer has not yet been evaluated.
Autor:
Andrew Kavee, Joellen M. Schildkraut, Philip J. Walther, Elizabeth Conlisk, David F. Paulson, Wendy Demark-Wahnefried, Eugene J. Lengerich, Christophe E. Iselin, Tim E. Aldrich
Publikováno v:
Cancer. 83:320-330
BACKGROUND In the U.S., prostate carcinoma mortality is greatest among African Americans. In North Carolina, the state with the fourth largest population of African Americans, the prostate carcinoma mortality rate is 2.5 times greater among African A
Autor:
Kenji Akie, Michihiro Fujino, Yoshikazu Kawakami, Hirotoshi Dosaka-Akita, Ichiro Kinoshita, Hiromitsu Hiroumi, Masao Harada
Publikováno v:
Cancer. 76:2457-2463
Background. Alterations of the p53 gene are one of the most common genetic changes in various types of cancer, including lung cancer. Abnormalities in the ras genes, including point mutations and overexpression, are another common feature in the mole
Publikováno v:
Cancer. 71:2746-2750
BACKGROUND The Jewish population of Israel is divided into two ethnic groups: Ashkenazic Jews (AJ) who immigrated from Europe and are fair-skinned, and Sephardic Jews (SJ) who immigrated from the Orient and Africa and who are dark-skinned. The biolog